Dr. Sara Gottfried strongly recommends a Coronary Artery Calcium (CAC) score, a CT scan of the chest, for all women by age 45. This simple, self-orderable test provides a critical assessment of cardiometabolic health, enabling early, personalized intervention for heart disease risk.

Androgen deprivation therapy induces metabolic syndrome-like effects, increasing cardiovascular risk. It is the medical oncologist's responsibility to perform a baseline CV risk assessment using tools like the STAMP questions and to engage cardiology partners when needed for risk mitigation.

Individuals have unique aging trajectories for different organs. By measuring organ-specific proteins in the blood, scientists can determine if your heart is aging faster than your brain, for example. This "age gap" is a strong predictor of future disease in that specific organ.

HDL cholesterol, typically seen as protective, can become dysfunctional in the presence of risk factors like smoking or obesity. This dysfunctional HDL then contributes to atherosclerosis instead of preventing it, challenging the simplistic 'good vs. bad' cholesterol narrative.

Individual early-detection tests like blood biopsies or MRIs are imperfect, leading to false positives and negatives. The next step in diagnostics is a "multimodal" approach, layering different screening types, such as genomic blood tests and imaging, to create a more accurate and comprehensive picture of a patient's health.

Focusing solely on LDL is a mistake. Even individuals with a genetic mutation leading to lifelong low LDL levels can still have cardiovascular events if they have other unmanaged risk factors like metabolic syndrome, obesity, or diabetes, highlighting the need for a comprehensive approach.

The silent nature of high cholesterol creates a psychological barrier. Patients who feel perfectly healthy are often unwilling to commit to lifelong treatment, even when their risk is high, leading to preventable cardiovascular events.

The body endogenously produces all the cholesterol necessary for vital functions. Optimal LDL levels are around 40 mg/dL, similar to a newborn's. Higher levels, typically from diet, are not needed and function like a toxin, initiating atherosclerosis.

Developing a blood test for a condition like Alzheimer's is complex because biomarkers like amyloid proteins can also be expressed due to other conditions, such as cardiovascular disease. This requires extensive population studies to understand confounding factors and ensure test accuracy.